|
VDP-92: Theranautilus - Magnetically manoeuvrable biohybrid stem cells
|
|
16
|
1013
|
January 31, 2024
|
|
VDP-140 - Tokenization of the ArtanBio IP-NFT
|
|
10
|
851
|
January 26, 2024
|
|
VDP-137: Hiring a Chief Scientific Officer (CSO) for VitaDAO
|
|
23
|
740
|
January 17, 2024
|
|
VDP-138 - Deciding VitaDAO’s next IPT
|
|
4
|
387
|
January 15, 2024
|
|
VDP-65 Introducing Delegated Voting
|
|
15
|
1606
|
January 11, 2024
|
|
VDP-135 VitaDAO Project Phase Out Protocol
|
|
2
|
448
|
December 30, 2023
|
|
VDP-131 [Assessment] Maxwell Biosciences
|
|
11
|
612
|
December 22, 2023
|
|
VDP-124 Company building management in VitaDAO
|
|
9
|
738
|
December 22, 2023
|
|
VDP-134 VitaDAO <> CryoDAO Partnership
|
|
15
|
857
|
February 10, 2024
|
|
VDP-132 [Funding] Mario Cordero - Multi-inflammasome inhibitors to treat aging and age-related diseases
|
|
7
|
640
|
January 3, 2024
|
|
VDP-123 [Assessment] Fission Pharma
|
|
7
|
865
|
December 17, 2023
|
|
VDP-133 - retroactive compensation for VitaDAO contributors to VDP-16/Korolchuk/VITA-FAST
|
|
12
|
708
|
December 5, 2023
|
|
VDP-125 - Rework - Scheibye-Knudsen Lab IP-NFT Asset
|
|
5
|
477
|
November 30, 2023
|
|
VDP-125 Proposal to Advance Scheibye-Knudsen Lab IP-NFT Asset
|
|
11
|
843
|
November 21, 2023
|
|
VDP-89 [Assessment] ExcepGen Inc. - RNA therapeutics for longevity
|
|
16
|
272
|
May 25, 2023
|
|
VDP-122 [Assessment]: Ora Biomedical - Healthy Aging Therapies For Next Generation Medicine
|
|
14
|
935
|
November 15, 2023
|
|
VDP-127: VitaDAO Ambassador Initiative
|
|
6
|
391
|
November 14, 2023
|
|
VDP-126 [Assessment] Remedium Bio
|
|
5
|
678
|
November 14, 2023
|
|
VDP-128 [Governance] The Network Steward role
|
|
4
|
347
|
November 18, 2023
|
|
VDP-129 [Assessment]: Vitalia - a city that builds longevity companies
|
|
4
|
523
|
November 17, 2023
|
|
VDP-130 [Governance]: VITA-FAST Community Growth and Operational Support Proposal
|
|
1
|
308
|
November 20, 2023
|
|
VDP-117 Magnaetus Therapeutics
|
|
2
|
633
|
September 13, 2023
|
|
VDP-121 Proposal to Mint 10% of Total Token Supply
|
|
2
|
467
|
October 20, 2023
|
|
VDP-118 [Assessment]: GERO - Machine Learning Platform for Age-Related Disease Targeting & Drug Discovery
|
|
12
|
870
|
September 19, 2023
|
|
VDP-116 [Funding] Mansarover: discovery platform for bifunctional compounds targeting FGF21+TGFß
|
|
8
|
692
|
August 25, 2023
|
|
VDP-119 Proposal to Empower Member Services Squad
|
|
1
|
495
|
October 20, 2023
|
|
VDP 108 [Governance] - Compensation Review
|
|
11
|
931
|
August 16, 2023
|
|
VDP-115: Ambassador Program
|
|
1
|
588
|
September 5, 2023
|
|
VDP-112 [Assessment] Cyclarity - Novel cyclodextrin molecules for multiple aging-related diseases
|
|
3
|
907
|
August 7, 2023
|
|
VDP-113 [Governance] - Incentive Structure Framework for IP-NFT Deals and Equity Assessments in VitaDAO
|
|
6
|
507
|
August 7, 2023
|